Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections

BACKGROUND: Antimicrobials for bloodstream infections due to ESBL- and AmpC-producing Escherichia coli and Klebsiella pneumoniae are significantly limited due to widespread antimicrobial resistance. Tebipenem, an oral carbapenem, exhibits stability against these resistance mechanisms and may prove a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranasinghe, Ama, Henderson, Andrew, Cottrell, Kyra, Tan, Cindy S E, Burnard, Delaney, Kato, Hideo, Paterson, David L, Harris, Patrick N A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524565/
https://www.ncbi.nlm.nih.gov/pubmed/36196442
http://dx.doi.org/10.1093/jacamr/dlac105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524565/
https://www.ncbi.nlm.nih.gov/pubmed/36196442
http://dx.doi.org/10.1093/jacamr/dlac105

Ejemplares similares